Cheil Bio Co., Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.
July 05, 2017 at 04:16 am
Share
Cheil Bio Co., Ltd. (KOSDAQ:A052670) announces a share repurchase program. Under the program, the company is authorized to repurchase KRW 2,000 million of its shares pursuant to a trust agreement with Mirae Asset Daewoo Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize the stock price. The program will expire on January 4, 2018. As of July 4, 2017, the company had 632,197 shares in treasury within scope available for dividend and had no shares in treasury through other repurchase.
Cheilbio Co., Ltd. is a Korea-based company engaged in the manufacturing of veterinary drugs. The Company's offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, diagnostic kits including enzyme-linked immunosorbent assay (ELISA) test kits, virus test kits and deoxyribonucleic acid (DNA) kits, as well as feed additives. The Companyâs products are used for cattle, pigs, chickens, pets and other animals. It supplies its products mainly to the domestic market.
CHEILBIO CO., LTD. 
